Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Republicans on Thursday advanced legislation that would require Iowa seek a federal approval to include work requirements as a condition of maintaining eligibility in the Iowa Health and Wellness Plan ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

There are various causes of lower abdominal pain, or lower belly pain. The conditions range in severity, from trapped gas or constipation to appendicitis, which requires immediate medical ...

Private Advisor Group LLC trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 38.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...

South Korean biosimilars developer Celltrion late yesterday announced new post-hoc analyses of its pivotal LIBERTY studies ...

Republicans this week advanced legislation that would require Iowa seek a federal approval to include work requirements as a ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

MrBeast is not just one of the most successful YouTubers of all time, he is also battling a serious illness. In a new podcast ...